Skip to main content

Instant redemption funds, UPI payments, KYC and more on the MobiKwik App!

Download
Home › Mutual Funds › Nippon Mutual Fund › Nippon India Pharma Fund - Bonus
Latest NAV & returns of NIPPON INDIA PRIVATE LTD.

Nippon India Pharma Fund - Bonus

Add To Compare

previously known as Reliance Pharma Bns until

NAV: ₹524.862 (-0.566%)
NAV on October 23, 2026
Category Equity:
Sector - Healthcare
Investment StyleBox
Total Assets ₹9,166 cr
Turnover Ratio 13.85%
Expense Ratio 1.84%
Exit Load 1.00%if redeemed within
1 Months0.00%if redeemed after 1 Months
Returns
  • 1M: Negative return: -9.20%
  • 1Y: Positive return: 1.71%
  • 3M: Negative return: -5.83%
  • 3Y: Positive return: 15.32%
  • 6M: Positive return: 2.32%
  • 5Y: Positive return: 11.86%
Min Investment ₹5,000
ADDITIONAL INFO
Fund Manager Sailesh Raj Bhan (Since over 21 years) Kinjal Desai (Since over 8 years) Amber Singhania (Since 8 months)
ISIN INF204K01950
Fund Family Nippon
P/E Ratio 37.98
P/B Ratio 5.60
Launch Date June 05, 2004
Benchmark BSE Healthcare TR INR

Asset Allocation

  • Equity: 97.3%
  • Debt: 2.7%
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs BSE Healthcare TR INR

Alpha -2.48
Beta 0.88
R-Squared 94.66
Info Ratio -1.17
Tracking Err 3.96
Sortino 1.125
Sharpe 0.696
Std Dev 15.056
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 0.0%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 100.00%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

View Factsheet

-

Best Sector Healthcare Funds

Name Latest NAV Returns 1y   Fund Assets Expense Ratio Risk
SBI MUTUAL FUND logo
SBI Healthcare Opportunities Fund Direct Growth
₹ 548.452 8.45% ₹ 5,870 cr 1.01% -
UTI ASSET MANAGEMENT COMPANY LTD. logo
UTI Healthcare Fund-Growth Option- Direct
₹ 354.642 6.98% ₹ 1,430 cr 1.34% -


Other plans of Nippon India Pharma


Other Equity funds by Nippon

Data Partner Morningstar Logo – Data Partner
Visit AMC website to read all scheme related documents Nippon Fund